RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma-Reference-Cited by-同舟云学术

RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma

Published:2017-05 Issue: Volume:63 Page:184-189
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Mendez-Pena Javier E.,Sadow Peter M.,Nose Vania,Hoang Mai P.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference22 articles.

1. The global health burden of infection-associated cancers in the year 2002;Parkin;Int J Cancer,2006

2. In situ hybridization analysis of human papillomavirus DNA segregation patterns in lesions of the female genital tract;Nuovo;Gynecol Oncol,1990

3. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status;Lewis;Am J Surg Pathol,2010

4. Five FDA-approved HPV assays;Lenhoff;MLO Med Lab Obs,2012

5. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma;Young;Br J Cancer,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology of Head and Neck Tumors;Molecular Surgical Pathology;2023

2. Rate of atypical nodal metastases in surgically treated HPV‐associated oropharyngeal squamous cell carcinoma;Head & Neck;2022-11-23

3. Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review;Molecular Diagnosis & Therapy;2021-12-26

4. Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer;Clinical Cancer Research;2021-12-02

5. Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus–associated nasopharyngeal carcinoma;Human Pathology;2021-11